Eurosurveillance

Your opinion counts: tell us what you think about the journal ✍🏽 https://bit.ly/EUSsurvey Whether you are a contributing author, reviewer, or reader of Eurosurveillance: we value your opinion and would love to hear about your experience with our journal Have your say and complete our survey so we can improve and continue to be relevant for the infectious disease community

Ce mercredi 22 Janvier, nous avons le plaisir de recevoir Ioannis Passaris, chercheur à Sciensano, dans le cadre des séminaires de maladies infectieuses et microbiologie clinique de Université libre de Bruxelles au UMC Sint-Pieter - CHU Saint-Pierre. Nous aborderons un thème d'actualité : la surveillance des infections à Pneumocoque et l'importance de considérer les infections non-invasives dans l 'élaboration de recommandations vaccinales, notamment par Superior Health Council of Belgium. Ioannis a récemment publié sa recherche dans la revue de référence en surveillance des maladies infectieuses en Europe, Eurosurveillance. Le séminaire sera donné sur place (avec un lunch servi) ou par Teams. Accréditation RIZIV-INAMI demandée.

January is #CervicalCancer awareness month! Did you know that cervical cancer is the second most common cancer, after breast cancer, to affect women aged 15–44 years in the European Union? Each year, there are around 33 000 cases of cervical cancer in the EU, and an estimated 15 000 deaths. There is however a way to get ourselves safer! HPV vaccination is highly effective in protecting against the human papillomavirus, which is responsible for the large majority of cervical cancers. Watch our short animation and learn more on the European Vaccination Information Portal in YOUR language! https://lnkd.in/dQSJfFeb or read more about the #CervicalCancerAwarenessMonth here: https://bit.ly/3ChCAm4

🗞️New study led by Rhiannon K Owen published in Eurosurveillance sheds light on the wider impact of #COVID19's deaths in Wales. The study demonstrates how linked data can provide vital insights into public health challenges. 👉Discover more https://lnkd.in/eCHj6AFS #linkeddata #pandemicimpact #publichealth HDR UK Wales Health Data Research UK (HDR UK) Population Data Science at Swansea University Swansea University Swansea University Medicine, Health and Life Science The University of Sheffield University of Warwick Warwick Statistics Keith R Abrams Warwick Medical School

📢 ECDC Webinar ➡️ Behavioural Science in Action: Using Behavioural Science to Counteract Antibiotic Resistance     What can social and behavioural science teach us about tackling antibiotic resistance?  🗓️ Monday 27 January 2025   🕕 15.30-16.30 CET  💻 Online     Join Prof. Michael Borg, head of the Department of Infection Prevention & Control at Mater Dei Hospital - Malta, and Dr. Tiina Likki, from the Behavioural and Cultural Insights Unit at the WHO Regional Office for Europe. Together, we will discuss the role of behavioural science in addressing the spread of antibiotic resistance and in the prevention of hospital-based infections, both from a clinical and practitioner perspective.   Don’t miss out on the discussion and share your perspectives with us! Register for the event here 👉 https://bit.ly/3C1hAQp #BehaviouralScience #AntimicrobialResistance #AMR #Prevention #PublicHealth

Our latest issue is out, featuring ➡️ a study looking at the number of cases of #Toscana virus (#TOSV) infection in Italy, with TOSV being a major cause of central nervous system disorders in the Mediterranean region in the summer ➡️ a study looking at how the COVID-19 pandemic affected the circulation levels of human para-influenza viruses (#HPIV) in Scotland 🗞️ Read it here: https://lnkd.in/dFnixUrX

After Japan lifted COVID-19 restrictions, it saw an increase in paediatric viral infections, including invasive infections caused by #echovirus 11 (#E11) and other #enteroviruses (EVs) in newborns. A study in our latest issue looks at 3 cases of echovirus 11 infections in newborns in Japan, and analyses their lineage to assess the relationship between local E11 strains and those reported in Europe: https://lnkd.in/d-54M7xj

On Thursday December 19th we have hold our last seminar at the Spanish National Center of Epidemiology (Instituto de Salud Carlos III) of the 2024. Susana Monge and Roberto Pastor has presented their study for assessing the #effectiveness of immunisation against to the Respiratory Sincitial Virus in new-borns using a new methodological approach to emulate RCTs. Susana Monge showed how Spain has been a pioneer country to implement the biological drug #Nirsevimab as a vaccine to avoid serious respiratory complications in the first days of life. She worried how to evaluate the effectiveness when the younger the age of the newborn and the seasonality of the #RSV wave difficulted to estimate the impact of this nationally-wide implemented public health measure. The senior mathematical researcher Roberto Pastor brought the light to a new methodological approach by using causal methods to emulate a massive RCT for a national representative sample of #newborns. Together with our also senior mathematician Olivier Nuñez they have developed the mimicking of a randomization process for the first time for a case-control design nested in a cohort using #observational data. The paper will be published in few weeks in the prestigious journal Eurosurveillance. We are excited to read not only the paper but also the hidden treasure of the supplementary material where all the methodological details will be unveiled.  

📢 Calling all science communication researchers! A group of us are organising a discussion session at the PCST conference in Aberdeen in May and I am looking for a researcher outside the EU to join us. Could that be you? The session is entitled: Will we ever overcome the misinformation crisis in science communication? We are looking for insights into the key causes of (science) misinformation in your region and ideas on solutions. So this would encompass research in related areas such as trust and expertise. It would involve a short, 5 min, presentation. If you would be interested in speaking (and aren't already at the maximum conference quota of contributing to 2 sessions) then please message me. #scicomm #journalism

#JustPublished! Epidemiological update - Transmission of monkeypox virus clade I: overall risk remains low in the EU/EEA. The first instances of confirmed transmission of monkeypox virus (#MPXV) clade I among close contacts of imported cases within the EU/EEA have been reported by Germany and Belgium. ECDC is in contact with national public health authorities in these countries regarding this recent development. 𝗧𝗵𝗲 𝗼𝘃𝗲𝗿𝗮𝗹𝗹 𝗿𝗶𝘀𝗸 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗘𝗨/𝗘𝗘𝗔 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗺𝗮𝗶𝗻𝘀 𝗹𝗼𝘄, 𝗮𝘀 𝗮𝘀𝘀𝗲𝘀𝘀𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗿𝗮𝗽𝗶𝗱 𝗿𝗶𝘀𝗸 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗯𝘆 𝗘𝗖𝗗𝗖 𝗼𝗻 𝟭𝟲 𝗔𝘂𝗴𝘂𝘀𝘁 𝟮𝟬𝟮𝟰. Press release: bit.ly/40I19lD Full text of the epidemiological update: bit.ly/3Pyo63Y #mpox